Global iPSC Therapy Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global iPSC Therapy market size was valued at US$ 92.27 million in 2025 and is forecast to a readjusted size of US$ 188 million by 2032 with a CAGR of 11.0% during review period.
iPSC Therapy (Induced Pluripotent Stem Cell Therapy) is an advanced regenerative medicine technology centered on induced pluripotent stem cells. In this approach, somatic cells such as skin or blood cells are reprogrammed by specific transcription factors to revert to a pluripotent state capable of differentiating into multiple cell types. These iPSCs can then be guided to develop into functional cells such as neurons, cardiomyocytes, retinal cells, or immune cells, which are used to replace or repair damaged tissues. iPSC therapy combines the pluripotency of embryonic stem cells with controllable cell sourcing, thereby avoiding major ethical concerns while enabling both personalized and standardized cell-based therapies. The technology shows significant potential in treating neurodegenerative diseases, cardiovascular disorders, ophthalmic conditions, cancer immunotherapy, and rare diseases. With continuous advances in cellular reprogramming, gene editing, and cell culture technologies, iPSC therapy is gradually transitioning from laboratory research to clinical applications and is becoming a key pillar of regenerative medicine and precision healthcare.
The market for iPSC therapy is driven by rapid advances in regenerative medicine and precision healthcare. The growing prevalence of chronic diseases, neurodegenerative disorders, and rare diseases highlights the limitations of conventional drug therapies in tissue repair and functional recovery, creating demand for cell-based treatments. iPSC technology provides a stable and expandable source of cells, supporting tissue regeneration, immune therapy, and disease modeling. Advances in gene editing and automated cell culture technologies are improving the safety, controllability, and scalability of cell therapy products. In addition, many governments worldwide are actively promoting the development of regenerative medicine through research funding, supportive policies, and industry collaboration, creating favorable conditions for the commercialization of iPSC-based therapies.
Despite its strong potential, iPSC therapy faces several challenges. The processes of cellular reprogramming and differentiation are complex and require strict control of culture conditions, quality assurance systems, and manufacturing standards. Potential risks such as tumorigenicity, immune rejection, and uncertainties regarding long-term therapeutic outcomes remain key concerns in clinical development. Regulatory authorities maintain rigorous approval procedures for cell-based therapies, resulting in long development timelines and high costs. In addition, supply chains for cell preparation, storage, and transportation are still evolving, which may affect the large-scale industrialization of the technology.
Downstream demand mainly comes from hospitals, biotechnology companies, and research institutions. As personalized medicine gains traction, demand for cell therapies targeting neurological disorders, cardiovascular diseases, and ophthalmic conditions continues to increase. iPSC-derived cells are also widely used in disease modeling, drug discovery, and toxicity testing, providing valuable platforms for pharmaceutical research. Healthcare providers and biopharmaceutical companies are increasingly exploring the therapeutic potential of cell-based treatments for complex diseases, driving continued growth in clinical research and industry partnerships. As manufacturing technologies mature and standardization improves, demand for iPSC therapy in both clinical treatment and drug development is expected to expand further.
The upstream segment of the iPSC therapy industry primarily includes cell culture media, growth factors, gene reprogramming vectors, and cell culture consumables. High-quality culture media and growth factors provide the necessary microenvironment for cell proliferation and differentiation and are essential components of cell production. Gene reprogramming tools, often based on viral or non-viral vector technologies, are used to introduce transcription factors into somatic cells to induce pluripotency. The production process also requires a large number of high-standard laboratory consumables such as culture dishes, flasks, and sterile filtration systems to maintain stable manufacturing conditions and consistent cell quality. With ongoing advancements in cell manufacturing technologies, automated culture equipment and advanced biomaterials are becoming increasingly important upstream components, supporting the technological progress of the entire cell therapy industry.
This report is a detailed and comprehensive analysis for global iPSC Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global iPSC Therapy market size and forecasts, in consumption value ($ Million), 2021-2032
Global iPSC Therapy market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global iPSC Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global iPSC Therapy market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for iPSC Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global iPSC Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fujifilm, Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL, Thermo Fisher Scientific, Sartorius, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
iPSC Therapy market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe iPSC Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of iPSC Therapy, with revenue, gross margin, and global market share of iPSC Therapy from 2021 to 2026.
Chapter 3, the iPSC Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and iPSC Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of iPSC Therapy.
Chapter 13, to describe iPSC Therapy research findings and conclusion.
iPSC Therapy (Induced Pluripotent Stem Cell Therapy) is an advanced regenerative medicine technology centered on induced pluripotent stem cells. In this approach, somatic cells such as skin or blood cells are reprogrammed by specific transcription factors to revert to a pluripotent state capable of differentiating into multiple cell types. These iPSCs can then be guided to develop into functional cells such as neurons, cardiomyocytes, retinal cells, or immune cells, which are used to replace or repair damaged tissues. iPSC therapy combines the pluripotency of embryonic stem cells with controllable cell sourcing, thereby avoiding major ethical concerns while enabling both personalized and standardized cell-based therapies. The technology shows significant potential in treating neurodegenerative diseases, cardiovascular disorders, ophthalmic conditions, cancer immunotherapy, and rare diseases. With continuous advances in cellular reprogramming, gene editing, and cell culture technologies, iPSC therapy is gradually transitioning from laboratory research to clinical applications and is becoming a key pillar of regenerative medicine and precision healthcare.
The market for iPSC therapy is driven by rapid advances in regenerative medicine and precision healthcare. The growing prevalence of chronic diseases, neurodegenerative disorders, and rare diseases highlights the limitations of conventional drug therapies in tissue repair and functional recovery, creating demand for cell-based treatments. iPSC technology provides a stable and expandable source of cells, supporting tissue regeneration, immune therapy, and disease modeling. Advances in gene editing and automated cell culture technologies are improving the safety, controllability, and scalability of cell therapy products. In addition, many governments worldwide are actively promoting the development of regenerative medicine through research funding, supportive policies, and industry collaboration, creating favorable conditions for the commercialization of iPSC-based therapies.
Despite its strong potential, iPSC therapy faces several challenges. The processes of cellular reprogramming and differentiation are complex and require strict control of culture conditions, quality assurance systems, and manufacturing standards. Potential risks such as tumorigenicity, immune rejection, and uncertainties regarding long-term therapeutic outcomes remain key concerns in clinical development. Regulatory authorities maintain rigorous approval procedures for cell-based therapies, resulting in long development timelines and high costs. In addition, supply chains for cell preparation, storage, and transportation are still evolving, which may affect the large-scale industrialization of the technology.
Downstream demand mainly comes from hospitals, biotechnology companies, and research institutions. As personalized medicine gains traction, demand for cell therapies targeting neurological disorders, cardiovascular diseases, and ophthalmic conditions continues to increase. iPSC-derived cells are also widely used in disease modeling, drug discovery, and toxicity testing, providing valuable platforms for pharmaceutical research. Healthcare providers and biopharmaceutical companies are increasingly exploring the therapeutic potential of cell-based treatments for complex diseases, driving continued growth in clinical research and industry partnerships. As manufacturing technologies mature and standardization improves, demand for iPSC therapy in both clinical treatment and drug development is expected to expand further.
The upstream segment of the iPSC therapy industry primarily includes cell culture media, growth factors, gene reprogramming vectors, and cell culture consumables. High-quality culture media and growth factors provide the necessary microenvironment for cell proliferation and differentiation and are essential components of cell production. Gene reprogramming tools, often based on viral or non-viral vector technologies, are used to introduce transcription factors into somatic cells to induce pluripotency. The production process also requires a large number of high-standard laboratory consumables such as culture dishes, flasks, and sterile filtration systems to maintain stable manufacturing conditions and consistent cell quality. With ongoing advancements in cell manufacturing technologies, automated culture equipment and advanced biomaterials are becoming increasingly important upstream components, supporting the technological progress of the entire cell therapy industry.
This report is a detailed and comprehensive analysis for global iPSC Therapy market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global iPSC Therapy market size and forecasts, in consumption value ($ Million), 2021-2032
Global iPSC Therapy market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global iPSC Therapy market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global iPSC Therapy market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for iPSC Therapy
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global iPSC Therapy market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Fujifilm, Ncardia, Sumitomo Dainippon Pharma, Astellas Pharma Inc, Fate Therapeutics, Inc, Pluricell Biotech, Cell Inspire Biotechnology, ReproCELL, Thermo Fisher Scientific, Sartorius, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
iPSC Therapy market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Human iPSCs
- Mouse iPSCs
- Hospitals
- Biotech Firms
- Research Institutes
- Neural Cells
- Cardiac Cells
- Retinal Cells
- Immune Cells
- Academic Research
- Drug Development and Discovery
- Toxicity Screening
- Regenerative Medicine
- Others
- Fujifilm
- Ncardia
- Sumitomo Dainippon Pharma
- Astellas Pharma Inc
- Fate Therapeutics, Inc
- Pluricell Biotech
- Cell Inspire Biotechnology
- ReproCELL
- Thermo Fisher Scientific
- Sartorius
- Bio-techne
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe iPSC Therapy product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of iPSC Therapy, with revenue, gross margin, and global market share of iPSC Therapy from 2021 to 2026.
Chapter 3, the iPSC Therapy competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and iPSC Therapy market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of iPSC Therapy.
Chapter 13, to describe iPSC Therapy research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of iPSC Therapy by Type
1.3.1 Overview: Global iPSC Therapy Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global iPSC Therapy Consumption Value Market Share by Type in 2025
1.3.3 Human iPSCs
1.3.4 Mouse iPSCs
1.4 Classification of iPSC Therapy by End User
1.4.1 Overview: Global iPSC Therapy Market Size by End User: 2021 Versus 2025 Versus 2032
1.4.2 Global iPSC Therapy Consumption Value Market Share by End User in 2025
1.4.3 Hospitals
1.4.4 Biotech Firms
1.4.5 Research Institutes
1.5 Classification of iPSC Therapy by Cell Type
1.5.1 Overview: Global iPSC Therapy Market Size by Cell Type: 2021 Versus 2025 Versus 2032
1.5.2 Global iPSC Therapy Consumption Value Market Share by Cell Type in 2025
1.5.3 Neural Cells
1.5.4 Cardiac Cells
1.5.5 Retinal Cells
1.5.6 Immune Cells
1.6 Global iPSC Therapy Market by Application
1.6.1 Overview: Global iPSC Therapy Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Academic Research
1.6.3 Drug Development and Discovery
1.6.4 Toxicity Screening
1.6.5 Regenerative Medicine
1.6.6 Others
1.7 Global iPSC Therapy Market Size & Forecast
1.8 Global iPSC Therapy Market Size and Forecast by Region
1.8.1 Global iPSC Therapy Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global iPSC Therapy Market Size by Region, (2021-2032)
1.8.3 North America iPSC Therapy Market Size and Prospect (2021-2032)
1.8.4 Europe iPSC Therapy Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific iPSC Therapy Market Size and Prospect (2021-2032)
1.8.6 South America iPSC Therapy Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa iPSC Therapy Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Fujifilm
2.1.1 Fujifilm Details
2.1.2 Fujifilm Major Business
2.1.3 Fujifilm iPSC Therapy Product and Solutions
2.1.4 Fujifilm iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Fujifilm Recent Developments and Future Plans
2.2 Ncardia
2.2.1 Ncardia Details
2.2.2 Ncardia Major Business
2.2.3 Ncardia iPSC Therapy Product and Solutions
2.2.4 Ncardia iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Ncardia Recent Developments and Future Plans
2.3 Sumitomo Dainippon Pharma
2.3.1 Sumitomo Dainippon Pharma Details
2.3.2 Sumitomo Dainippon Pharma Major Business
2.3.3 Sumitomo Dainippon Pharma iPSC Therapy Product and Solutions
2.3.4 Sumitomo Dainippon Pharma iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Sumitomo Dainippon Pharma Recent Developments and Future Plans
2.4 Astellas Pharma Inc
2.4.1 Astellas Pharma Inc Details
2.4.2 Astellas Pharma Inc Major Business
2.4.3 Astellas Pharma Inc iPSC Therapy Product and Solutions
2.4.4 Astellas Pharma Inc iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Astellas Pharma Inc Recent Developments and Future Plans
2.5 Fate Therapeutics, Inc
2.5.1 Fate Therapeutics, Inc Details
2.5.2 Fate Therapeutics, Inc Major Business
2.5.3 Fate Therapeutics, Inc iPSC Therapy Product and Solutions
2.5.4 Fate Therapeutics, Inc iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Fate Therapeutics, Inc Recent Developments and Future Plans
2.6 Pluricell Biotech
2.6.1 Pluricell Biotech Details
2.6.2 Pluricell Biotech Major Business
2.6.3 Pluricell Biotech iPSC Therapy Product and Solutions
2.6.4 Pluricell Biotech iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Pluricell Biotech Recent Developments and Future Plans
2.7 Cell Inspire Biotechnology
2.7.1 Cell Inspire Biotechnology Details
2.7.2 Cell Inspire Biotechnology Major Business
2.7.3 Cell Inspire Biotechnology iPSC Therapy Product and Solutions
2.7.4 Cell Inspire Biotechnology iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Cell Inspire Biotechnology Recent Developments and Future Plans
2.8 ReproCELL
2.8.1 ReproCELL Details
2.8.2 ReproCELL Major Business
2.8.3 ReproCELL iPSC Therapy Product and Solutions
2.8.4 ReproCELL iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 ReproCELL Recent Developments and Future Plans
2.9 Thermo Fisher Scientific
2.9.1 Thermo Fisher Scientific Details
2.9.2 Thermo Fisher Scientific Major Business
2.9.3 Thermo Fisher Scientific iPSC Therapy Product and Solutions
2.9.4 Thermo Fisher Scientific iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.10 Sartorius
2.10.1 Sartorius Details
2.10.2 Sartorius Major Business
2.10.3 Sartorius iPSC Therapy Product and Solutions
2.10.4 Sartorius iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Sartorius Recent Developments and Future Plans
2.11 Bio-techne
2.11.1 Bio-techne Details
2.11.2 Bio-techne Major Business
2.11.3 Bio-techne iPSC Therapy Product and Solutions
2.11.4 Bio-techne iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Bio-techne Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global iPSC Therapy Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of iPSC Therapy by Company Revenue
3.2.2 Top 3 iPSC Therapy Players Market Share in 2025
3.2.3 Top 6 iPSC Therapy Players Market Share in 2025
3.3 iPSC Therapy Market: Overall Company Footprint Analysis
3.3.1 iPSC Therapy Market: Region Footprint
3.3.2 iPSC Therapy Market: Company Product Type Footprint
3.3.3 iPSC Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global iPSC Therapy Consumption Value and Market Share by Type (2021-2026)
4.2 Global iPSC Therapy Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global iPSC Therapy Consumption Value Market Share by Application (2021-2026)
5.2 Global iPSC Therapy Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America iPSC Therapy Consumption Value by Type (2021-2032)
6.2 North America iPSC Therapy Market Size by Application (2021-2032)
6.3 North America iPSC Therapy Market Size by Country
6.3.1 North America iPSC Therapy Consumption Value by Country (2021-2032)
6.3.2 United States iPSC Therapy Market Size and Forecast (2021-2032)
6.3.3 Canada iPSC Therapy Market Size and Forecast (2021-2032)
6.3.4 Mexico iPSC Therapy Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe iPSC Therapy Consumption Value by Type (2021-2032)
7.2 Europe iPSC Therapy Consumption Value by Application (2021-2032)
7.3 Europe iPSC Therapy Market Size by Country
7.3.1 Europe iPSC Therapy Consumption Value by Country (2021-2032)
7.3.2 Germany iPSC Therapy Market Size and Forecast (2021-2032)
7.3.3 France iPSC Therapy Market Size and Forecast (2021-2032)
7.3.4 United Kingdom iPSC Therapy Market Size and Forecast (2021-2032)
7.3.5 Russia iPSC Therapy Market Size and Forecast (2021-2032)
7.3.6 Italy iPSC Therapy Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific iPSC Therapy Consumption Value by Type (2021-2032)
8.2 Asia-Pacific iPSC Therapy Consumption Value by Application (2021-2032)
8.3 Asia-Pacific iPSC Therapy Market Size by Region
8.3.1 Asia-Pacific iPSC Therapy Consumption Value by Region (2021-2032)
8.3.2 China iPSC Therapy Market Size and Forecast (2021-2032)
8.3.3 Japan iPSC Therapy Market Size and Forecast (2021-2032)
8.3.4 South Korea iPSC Therapy Market Size and Forecast (2021-2032)
8.3.5 India iPSC Therapy Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia iPSC Therapy Market Size and Forecast (2021-2032)
8.3.7 Australia iPSC Therapy Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America iPSC Therapy Consumption Value by Type (2021-2032)
9.2 South America iPSC Therapy Consumption Value by Application (2021-2032)
9.3 South America iPSC Therapy Market Size by Country
9.3.1 South America iPSC Therapy Consumption Value by Country (2021-2032)
9.3.2 Brazil iPSC Therapy Market Size and Forecast (2021-2032)
9.3.3 Argentina iPSC Therapy Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa iPSC Therapy Consumption Value by Type (2021-2032)
10.2 Middle East & Africa iPSC Therapy Consumption Value by Application (2021-2032)
10.3 Middle East & Africa iPSC Therapy Market Size by Country
10.3.1 Middle East & Africa iPSC Therapy Consumption Value by Country (2021-2032)
10.3.2 Turkey iPSC Therapy Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia iPSC Therapy Market Size and Forecast (2021-2032)
10.3.4 UAE iPSC Therapy Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 iPSC Therapy Market Drivers
11.2 iPSC Therapy Market Restraints
11.3 iPSC Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 iPSC Therapy Industry Chain
12.2 iPSC Therapy Upstream Analysis
12.3 iPSC Therapy Midstream Analysis
12.4 iPSC Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of iPSC Therapy by Type
1.3.1 Overview: Global iPSC Therapy Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global iPSC Therapy Consumption Value Market Share by Type in 2025
1.3.3 Human iPSCs
1.3.4 Mouse iPSCs
1.4 Classification of iPSC Therapy by End User
1.4.1 Overview: Global iPSC Therapy Market Size by End User: 2021 Versus 2025 Versus 2032
1.4.2 Global iPSC Therapy Consumption Value Market Share by End User in 2025
1.4.3 Hospitals
1.4.4 Biotech Firms
1.4.5 Research Institutes
1.5 Classification of iPSC Therapy by Cell Type
1.5.1 Overview: Global iPSC Therapy Market Size by Cell Type: 2021 Versus 2025 Versus 2032
1.5.2 Global iPSC Therapy Consumption Value Market Share by Cell Type in 2025
1.5.3 Neural Cells
1.5.4 Cardiac Cells
1.5.5 Retinal Cells
1.5.6 Immune Cells
1.6 Global iPSC Therapy Market by Application
1.6.1 Overview: Global iPSC Therapy Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Academic Research
1.6.3 Drug Development and Discovery
1.6.4 Toxicity Screening
1.6.5 Regenerative Medicine
1.6.6 Others
1.7 Global iPSC Therapy Market Size & Forecast
1.8 Global iPSC Therapy Market Size and Forecast by Region
1.8.1 Global iPSC Therapy Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global iPSC Therapy Market Size by Region, (2021-2032)
1.8.3 North America iPSC Therapy Market Size and Prospect (2021-2032)
1.8.4 Europe iPSC Therapy Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific iPSC Therapy Market Size and Prospect (2021-2032)
1.8.6 South America iPSC Therapy Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa iPSC Therapy Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 Fujifilm
2.1.1 Fujifilm Details
2.1.2 Fujifilm Major Business
2.1.3 Fujifilm iPSC Therapy Product and Solutions
2.1.4 Fujifilm iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 Fujifilm Recent Developments and Future Plans
2.2 Ncardia
2.2.1 Ncardia Details
2.2.2 Ncardia Major Business
2.2.3 Ncardia iPSC Therapy Product and Solutions
2.2.4 Ncardia iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 Ncardia Recent Developments and Future Plans
2.3 Sumitomo Dainippon Pharma
2.3.1 Sumitomo Dainippon Pharma Details
2.3.2 Sumitomo Dainippon Pharma Major Business
2.3.3 Sumitomo Dainippon Pharma iPSC Therapy Product and Solutions
2.3.4 Sumitomo Dainippon Pharma iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Sumitomo Dainippon Pharma Recent Developments and Future Plans
2.4 Astellas Pharma Inc
2.4.1 Astellas Pharma Inc Details
2.4.2 Astellas Pharma Inc Major Business
2.4.3 Astellas Pharma Inc iPSC Therapy Product and Solutions
2.4.4 Astellas Pharma Inc iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 Astellas Pharma Inc Recent Developments and Future Plans
2.5 Fate Therapeutics, Inc
2.5.1 Fate Therapeutics, Inc Details
2.5.2 Fate Therapeutics, Inc Major Business
2.5.3 Fate Therapeutics, Inc iPSC Therapy Product and Solutions
2.5.4 Fate Therapeutics, Inc iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Fate Therapeutics, Inc Recent Developments and Future Plans
2.6 Pluricell Biotech
2.6.1 Pluricell Biotech Details
2.6.2 Pluricell Biotech Major Business
2.6.3 Pluricell Biotech iPSC Therapy Product and Solutions
2.6.4 Pluricell Biotech iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Pluricell Biotech Recent Developments and Future Plans
2.7 Cell Inspire Biotechnology
2.7.1 Cell Inspire Biotechnology Details
2.7.2 Cell Inspire Biotechnology Major Business
2.7.3 Cell Inspire Biotechnology iPSC Therapy Product and Solutions
2.7.4 Cell Inspire Biotechnology iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Cell Inspire Biotechnology Recent Developments and Future Plans
2.8 ReproCELL
2.8.1 ReproCELL Details
2.8.2 ReproCELL Major Business
2.8.3 ReproCELL iPSC Therapy Product and Solutions
2.8.4 ReproCELL iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.8.5 ReproCELL Recent Developments and Future Plans
2.9 Thermo Fisher Scientific
2.9.1 Thermo Fisher Scientific Details
2.9.2 Thermo Fisher Scientific Major Business
2.9.3 Thermo Fisher Scientific iPSC Therapy Product and Solutions
2.9.4 Thermo Fisher Scientific iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.9.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.10 Sartorius
2.10.1 Sartorius Details
2.10.2 Sartorius Major Business
2.10.3 Sartorius iPSC Therapy Product and Solutions
2.10.4 Sartorius iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.10.5 Sartorius Recent Developments and Future Plans
2.11 Bio-techne
2.11.1 Bio-techne Details
2.11.2 Bio-techne Major Business
2.11.3 Bio-techne iPSC Therapy Product and Solutions
2.11.4 Bio-techne iPSC Therapy Revenue, Gross Margin and Market Share (2021-2026)
2.11.5 Bio-techne Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global iPSC Therapy Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of iPSC Therapy by Company Revenue
3.2.2 Top 3 iPSC Therapy Players Market Share in 2025
3.2.3 Top 6 iPSC Therapy Players Market Share in 2025
3.3 iPSC Therapy Market: Overall Company Footprint Analysis
3.3.1 iPSC Therapy Market: Region Footprint
3.3.2 iPSC Therapy Market: Company Product Type Footprint
3.3.3 iPSC Therapy Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global iPSC Therapy Consumption Value and Market Share by Type (2021-2026)
4.2 Global iPSC Therapy Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global iPSC Therapy Consumption Value Market Share by Application (2021-2026)
5.2 Global iPSC Therapy Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America iPSC Therapy Consumption Value by Type (2021-2032)
6.2 North America iPSC Therapy Market Size by Application (2021-2032)
6.3 North America iPSC Therapy Market Size by Country
6.3.1 North America iPSC Therapy Consumption Value by Country (2021-2032)
6.3.2 United States iPSC Therapy Market Size and Forecast (2021-2032)
6.3.3 Canada iPSC Therapy Market Size and Forecast (2021-2032)
6.3.4 Mexico iPSC Therapy Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe iPSC Therapy Consumption Value by Type (2021-2032)
7.2 Europe iPSC Therapy Consumption Value by Application (2021-2032)
7.3 Europe iPSC Therapy Market Size by Country
7.3.1 Europe iPSC Therapy Consumption Value by Country (2021-2032)
7.3.2 Germany iPSC Therapy Market Size and Forecast (2021-2032)
7.3.3 France iPSC Therapy Market Size and Forecast (2021-2032)
7.3.4 United Kingdom iPSC Therapy Market Size and Forecast (2021-2032)
7.3.5 Russia iPSC Therapy Market Size and Forecast (2021-2032)
7.3.6 Italy iPSC Therapy Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific iPSC Therapy Consumption Value by Type (2021-2032)
8.2 Asia-Pacific iPSC Therapy Consumption Value by Application (2021-2032)
8.3 Asia-Pacific iPSC Therapy Market Size by Region
8.3.1 Asia-Pacific iPSC Therapy Consumption Value by Region (2021-2032)
8.3.2 China iPSC Therapy Market Size and Forecast (2021-2032)
8.3.3 Japan iPSC Therapy Market Size and Forecast (2021-2032)
8.3.4 South Korea iPSC Therapy Market Size and Forecast (2021-2032)
8.3.5 India iPSC Therapy Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia iPSC Therapy Market Size and Forecast (2021-2032)
8.3.7 Australia iPSC Therapy Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America iPSC Therapy Consumption Value by Type (2021-2032)
9.2 South America iPSC Therapy Consumption Value by Application (2021-2032)
9.3 South America iPSC Therapy Market Size by Country
9.3.1 South America iPSC Therapy Consumption Value by Country (2021-2032)
9.3.2 Brazil iPSC Therapy Market Size and Forecast (2021-2032)
9.3.3 Argentina iPSC Therapy Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa iPSC Therapy Consumption Value by Type (2021-2032)
10.2 Middle East & Africa iPSC Therapy Consumption Value by Application (2021-2032)
10.3 Middle East & Africa iPSC Therapy Market Size by Country
10.3.1 Middle East & Africa iPSC Therapy Consumption Value by Country (2021-2032)
10.3.2 Turkey iPSC Therapy Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia iPSC Therapy Market Size and Forecast (2021-2032)
10.3.4 UAE iPSC Therapy Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 iPSC Therapy Market Drivers
11.2 iPSC Therapy Market Restraints
11.3 iPSC Therapy Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 iPSC Therapy Industry Chain
12.2 iPSC Therapy Upstream Analysis
12.3 iPSC Therapy Midstream Analysis
12.4 iPSC Therapy Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global iPSC Therapy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global iPSC Therapy Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Table 3. Global iPSC Therapy Consumption Value by Cell Type, (USD Million), 2021 & 2025 & 2032
Table 4. Global iPSC Therapy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global iPSC Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global iPSC Therapy Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Fujifilm Company Information, Head Office, and Major Competitors
Table 8. Fujifilm Major Business
Table 9. Fujifilm iPSC Therapy Product and Solutions
Table 10. Fujifilm iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Fujifilm Recent Developments and Future Plans
Table 12. Ncardia Company Information, Head Office, and Major Competitors
Table 13. Ncardia Major Business
Table 14. Ncardia iPSC Therapy Product and Solutions
Table 15. Ncardia iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Ncardia Recent Developments and Future Plans
Table 17. Sumitomo Dainippon Pharma Company Information, Head Office, and Major Competitors
Table 18. Sumitomo Dainippon Pharma Major Business
Table 19. Sumitomo Dainippon Pharma iPSC Therapy Product and Solutions
Table 20. Sumitomo Dainippon Pharma iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Astellas Pharma Inc Company Information, Head Office, and Major Competitors
Table 22. Astellas Pharma Inc Major Business
Table 23. Astellas Pharma Inc iPSC Therapy Product and Solutions
Table 24. Astellas Pharma Inc iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Astellas Pharma Inc Recent Developments and Future Plans
Table 26. Fate Therapeutics, Inc Company Information, Head Office, and Major Competitors
Table 27. Fate Therapeutics, Inc Major Business
Table 28. Fate Therapeutics, Inc iPSC Therapy Product and Solutions
Table 29. Fate Therapeutics, Inc iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Fate Therapeutics, Inc Recent Developments and Future Plans
Table 31. Pluricell Biotech Company Information, Head Office, and Major Competitors
Table 32. Pluricell Biotech Major Business
Table 33. Pluricell Biotech iPSC Therapy Product and Solutions
Table 34. Pluricell Biotech iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Pluricell Biotech Recent Developments and Future Plans
Table 36. Cell Inspire Biotechnology Company Information, Head Office, and Major Competitors
Table 37. Cell Inspire Biotechnology Major Business
Table 38. Cell Inspire Biotechnology iPSC Therapy Product and Solutions
Table 39. Cell Inspire Biotechnology iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Cell Inspire Biotechnology Recent Developments and Future Plans
Table 41. ReproCELL Company Information, Head Office, and Major Competitors
Table 42. ReproCELL Major Business
Table 43. ReproCELL iPSC Therapy Product and Solutions
Table 44. ReproCELL iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. ReproCELL Recent Developments and Future Plans
Table 46. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 47. Thermo Fisher Scientific Major Business
Table 48. Thermo Fisher Scientific iPSC Therapy Product and Solutions
Table 49. Thermo Fisher Scientific iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Thermo Fisher Scientific Recent Developments and Future Plans
Table 51. Sartorius Company Information, Head Office, and Major Competitors
Table 52. Sartorius Major Business
Table 53. Sartorius iPSC Therapy Product and Solutions
Table 54. Sartorius iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Sartorius Recent Developments and Future Plans
Table 56. Bio-techne Company Information, Head Office, and Major Competitors
Table 57. Bio-techne Major Business
Table 58. Bio-techne iPSC Therapy Product and Solutions
Table 59. Bio-techne iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Bio-techne Recent Developments and Future Plans
Table 61. Global iPSC Therapy Revenue (USD Million) by Players (2021-2026)
Table 62. Global iPSC Therapy Revenue Share by Players (2021-2026)
Table 63. Breakdown of iPSC Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 64. Market Position of Players in iPSC Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 65. Head Office of Key iPSC Therapy Players
Table 66. iPSC Therapy Market: Company Product Type Footprint
Table 67. iPSC Therapy Market: Company Product Application Footprint
Table 68. iPSC Therapy New Market Entrants and Barriers to Market Entry
Table 69. iPSC Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 70. Global iPSC Therapy Consumption Value (USD Million) by Type (2021-2026)
Table 71. Global iPSC Therapy Consumption Value Share by Type (2021-2026)
Table 72. Global iPSC Therapy Consumption Value Forecast by Type (2027-2032)
Table 73. Global iPSC Therapy Consumption Value by Application (2021-2026)
Table 74. Global iPSC Therapy Consumption Value Forecast by Application (2027-2032)
Table 75. North America iPSC Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 76. North America iPSC Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 77. North America iPSC Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 78. North America iPSC Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 79. North America iPSC Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 80. North America iPSC Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 81. Europe iPSC Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 82. Europe iPSC Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 83. Europe iPSC Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 84. Europe iPSC Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 85. Europe iPSC Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 86. Europe iPSC Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 87. Asia-Pacific iPSC Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 88. Asia-Pacific iPSC Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 89. Asia-Pacific iPSC Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 90. Asia-Pacific iPSC Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 91. Asia-Pacific iPSC Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 92. Asia-Pacific iPSC Therapy Consumption Value by Region (2027-2032) & (USD Million)
Table 93. South America iPSC Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 94. South America iPSC Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 95. South America iPSC Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 96. South America iPSC Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 97. South America iPSC Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 98. South America iPSC Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 99. Middle East & Africa iPSC Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 100. Middle East & Africa iPSC Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 101. Middle East & Africa iPSC Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 102. Middle East & Africa iPSC Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 103. Middle East & Africa iPSC Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa iPSC Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 105. Global Key Players of iPSC Therapy Upstream (Raw Materials)
Table 106. Global iPSC Therapy Typical Customers
Table 1. Global iPSC Therapy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global iPSC Therapy Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Table 3. Global iPSC Therapy Consumption Value by Cell Type, (USD Million), 2021 & 2025 & 2032
Table 4. Global iPSC Therapy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global iPSC Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global iPSC Therapy Consumption Value by Region (2027-2032) & (USD Million)
Table 7. Fujifilm Company Information, Head Office, and Major Competitors
Table 8. Fujifilm Major Business
Table 9. Fujifilm iPSC Therapy Product and Solutions
Table 10. Fujifilm iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. Fujifilm Recent Developments and Future Plans
Table 12. Ncardia Company Information, Head Office, and Major Competitors
Table 13. Ncardia Major Business
Table 14. Ncardia iPSC Therapy Product and Solutions
Table 15. Ncardia iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. Ncardia Recent Developments and Future Plans
Table 17. Sumitomo Dainippon Pharma Company Information, Head Office, and Major Competitors
Table 18. Sumitomo Dainippon Pharma Major Business
Table 19. Sumitomo Dainippon Pharma iPSC Therapy Product and Solutions
Table 20. Sumitomo Dainippon Pharma iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. Astellas Pharma Inc Company Information, Head Office, and Major Competitors
Table 22. Astellas Pharma Inc Major Business
Table 23. Astellas Pharma Inc iPSC Therapy Product and Solutions
Table 24. Astellas Pharma Inc iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. Astellas Pharma Inc Recent Developments and Future Plans
Table 26. Fate Therapeutics, Inc Company Information, Head Office, and Major Competitors
Table 27. Fate Therapeutics, Inc Major Business
Table 28. Fate Therapeutics, Inc iPSC Therapy Product and Solutions
Table 29. Fate Therapeutics, Inc iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Fate Therapeutics, Inc Recent Developments and Future Plans
Table 31. Pluricell Biotech Company Information, Head Office, and Major Competitors
Table 32. Pluricell Biotech Major Business
Table 33. Pluricell Biotech iPSC Therapy Product and Solutions
Table 34. Pluricell Biotech iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Pluricell Biotech Recent Developments and Future Plans
Table 36. Cell Inspire Biotechnology Company Information, Head Office, and Major Competitors
Table 37. Cell Inspire Biotechnology Major Business
Table 38. Cell Inspire Biotechnology iPSC Therapy Product and Solutions
Table 39. Cell Inspire Biotechnology iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Cell Inspire Biotechnology Recent Developments and Future Plans
Table 41. ReproCELL Company Information, Head Office, and Major Competitors
Table 42. ReproCELL Major Business
Table 43. ReproCELL iPSC Therapy Product and Solutions
Table 44. ReproCELL iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 45. ReproCELL Recent Developments and Future Plans
Table 46. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 47. Thermo Fisher Scientific Major Business
Table 48. Thermo Fisher Scientific iPSC Therapy Product and Solutions
Table 49. Thermo Fisher Scientific iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 50. Thermo Fisher Scientific Recent Developments and Future Plans
Table 51. Sartorius Company Information, Head Office, and Major Competitors
Table 52. Sartorius Major Business
Table 53. Sartorius iPSC Therapy Product and Solutions
Table 54. Sartorius iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 55. Sartorius Recent Developments and Future Plans
Table 56. Bio-techne Company Information, Head Office, and Major Competitors
Table 57. Bio-techne Major Business
Table 58. Bio-techne iPSC Therapy Product and Solutions
Table 59. Bio-techne iPSC Therapy Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 60. Bio-techne Recent Developments and Future Plans
Table 61. Global iPSC Therapy Revenue (USD Million) by Players (2021-2026)
Table 62. Global iPSC Therapy Revenue Share by Players (2021-2026)
Table 63. Breakdown of iPSC Therapy by Company Type (Tier 1, Tier 2, and Tier 3)
Table 64. Market Position of Players in iPSC Therapy, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 65. Head Office of Key iPSC Therapy Players
Table 66. iPSC Therapy Market: Company Product Type Footprint
Table 67. iPSC Therapy Market: Company Product Application Footprint
Table 68. iPSC Therapy New Market Entrants and Barriers to Market Entry
Table 69. iPSC Therapy Mergers, Acquisition, Agreements, and Collaborations
Table 70. Global iPSC Therapy Consumption Value (USD Million) by Type (2021-2026)
Table 71. Global iPSC Therapy Consumption Value Share by Type (2021-2026)
Table 72. Global iPSC Therapy Consumption Value Forecast by Type (2027-2032)
Table 73. Global iPSC Therapy Consumption Value by Application (2021-2026)
Table 74. Global iPSC Therapy Consumption Value Forecast by Application (2027-2032)
Table 75. North America iPSC Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 76. North America iPSC Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 77. North America iPSC Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 78. North America iPSC Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 79. North America iPSC Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 80. North America iPSC Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 81. Europe iPSC Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 82. Europe iPSC Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 83. Europe iPSC Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 84. Europe iPSC Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 85. Europe iPSC Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 86. Europe iPSC Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 87. Asia-Pacific iPSC Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 88. Asia-Pacific iPSC Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 89. Asia-Pacific iPSC Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 90. Asia-Pacific iPSC Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 91. Asia-Pacific iPSC Therapy Consumption Value by Region (2021-2026) & (USD Million)
Table 92. Asia-Pacific iPSC Therapy Consumption Value by Region (2027-2032) & (USD Million)
Table 93. South America iPSC Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 94. South America iPSC Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 95. South America iPSC Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 96. South America iPSC Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 97. South America iPSC Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 98. South America iPSC Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 99. Middle East & Africa iPSC Therapy Consumption Value by Type (2021-2026) & (USD Million)
Table 100. Middle East & Africa iPSC Therapy Consumption Value by Type (2027-2032) & (USD Million)
Table 101. Middle East & Africa iPSC Therapy Consumption Value by Application (2021-2026) & (USD Million)
Table 102. Middle East & Africa iPSC Therapy Consumption Value by Application (2027-2032) & (USD Million)
Table 103. Middle East & Africa iPSC Therapy Consumption Value by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa iPSC Therapy Consumption Value by Country (2027-2032) & (USD Million)
Table 105. Global Key Players of iPSC Therapy Upstream (Raw Materials)
Table 106. Global iPSC Therapy Typical Customers
LIST OF FIGURES
Figure 1. iPSC Therapy Picture
Figure 2. Global iPSC Therapy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global iPSC Therapy Consumption Value Market Share by Type in 2025
Figure 4. Human iPSCs
Figure 5. Mouse iPSCs
Figure 6. Global iPSC Therapy Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Figure 7. Global iPSC Therapy Consumption Value Market Share by End User in 2025
Figure 8. Hospitals
Figure 9. Biotech Firms
Figure 10. Research Institutes
Figure 11. Global iPSC Therapy Consumption Value by Cell Type, (USD Million), 2021 & 2025 & 2032
Figure 12. Global iPSC Therapy Consumption Value Market Share by Cell Type in 2025
Figure 13. Neural Cells
Figure 14. Cardiac Cells
Figure 15. Retinal Cells
Figure 16. Immune Cells
Figure 17. Global iPSC Therapy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. iPSC Therapy Consumption Value Market Share by Application in 2025
Figure 19. Academic Research Picture
Figure 20. Drug Development and Discovery Picture
Figure 21. Toxicity Screening Picture
Figure 22. Regenerative Medicine Picture
Figure 23. Others Picture
Figure 24. Global iPSC Therapy Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global iPSC Therapy Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Market iPSC Therapy Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 27. Global iPSC Therapy Consumption Value Market Share by Region (2021-2032)
Figure 28. Global iPSC Therapy Consumption Value Market Share by Region in 2025
Figure 29. North America iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 32. South America iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 34. Company Three Recent Developments and Future Plans
Figure 35. Global iPSC Therapy Revenue Share by Players in 2025
Figure 36. iPSC Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 37. Market Share of iPSC Therapy by Player Revenue in 2025
Figure 38. Top 3 iPSC Therapy Players Market Share in 2025
Figure 39. Top 6 iPSC Therapy Players Market Share in 2025
Figure 40. Global iPSC Therapy Consumption Value Share by Type (2021-2026)
Figure 41. Global iPSC Therapy Market Share Forecast by Type (2027-2032)
Figure 42. Global iPSC Therapy Consumption Value Share by Application (2021-2026)
Figure 43. Global iPSC Therapy Market Share Forecast by Application (2027-2032)
Figure 44. North America iPSC Therapy Consumption Value Market Share by Type (2021-2032)
Figure 45. North America iPSC Therapy Consumption Value Market Share by Application (2021-2032)
Figure 46. North America iPSC Therapy Consumption Value Market Share by Country (2021-2032)
Figure 47. United States iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe iPSC Therapy Consumption Value Market Share by Type (2021-2032)
Figure 51. Europe iPSC Therapy Consumption Value Market Share by Application (2021-2032)
Figure 52. Europe iPSC Therapy Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 54. France iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific iPSC Therapy Consumption Value Market Share by Type (2021-2032)
Figure 59. Asia-Pacific iPSC Therapy Consumption Value Market Share by Application (2021-2032)
Figure 60. Asia-Pacific iPSC Therapy Consumption Value Market Share by Region (2021-2032)
Figure 61. China iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 62. Japan iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 63. South Korea iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 64. India iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 65. Southeast Asia iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 66. Australia iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 67. South America iPSC Therapy Consumption Value Market Share by Type (2021-2032)
Figure 68. South America iPSC Therapy Consumption Value Market Share by Application (2021-2032)
Figure 69. South America iPSC Therapy Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa iPSC Therapy Consumption Value Market Share by Type (2021-2032)
Figure 73. Middle East & Africa iPSC Therapy Consumption Value Market Share by Application (2021-2032)
Figure 74. Middle East & Africa iPSC Therapy Consumption Value Market Share by Country (2021-2032)
Figure 75. Turkey iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 76. Saudi Arabia iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 77. UAE iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 78. iPSC Therapy Market Drivers
Figure 79. iPSC Therapy Market Restraints
Figure 80. iPSC Therapy Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. iPSC Therapy Industrial Chain
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. iPSC Therapy Picture
Figure 2. Global iPSC Therapy Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global iPSC Therapy Consumption Value Market Share by Type in 2025
Figure 4. Human iPSCs
Figure 5. Mouse iPSCs
Figure 6. Global iPSC Therapy Consumption Value by End User, (USD Million), 2021 & 2025 & 2032
Figure 7. Global iPSC Therapy Consumption Value Market Share by End User in 2025
Figure 8. Hospitals
Figure 9. Biotech Firms
Figure 10. Research Institutes
Figure 11. Global iPSC Therapy Consumption Value by Cell Type, (USD Million), 2021 & 2025 & 2032
Figure 12. Global iPSC Therapy Consumption Value Market Share by Cell Type in 2025
Figure 13. Neural Cells
Figure 14. Cardiac Cells
Figure 15. Retinal Cells
Figure 16. Immune Cells
Figure 17. Global iPSC Therapy Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 18. iPSC Therapy Consumption Value Market Share by Application in 2025
Figure 19. Academic Research Picture
Figure 20. Drug Development and Discovery Picture
Figure 21. Toxicity Screening Picture
Figure 22. Regenerative Medicine Picture
Figure 23. Others Picture
Figure 24. Global iPSC Therapy Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 25. Global iPSC Therapy Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 26. Global Market iPSC Therapy Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 27. Global iPSC Therapy Consumption Value Market Share by Region (2021-2032)
Figure 28. Global iPSC Therapy Consumption Value Market Share by Region in 2025
Figure 29. North America iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 30. Europe iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 31. Asia-Pacific iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 32. South America iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 33. Middle East & Africa iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 34. Company Three Recent Developments and Future Plans
Figure 35. Global iPSC Therapy Revenue Share by Players in 2025
Figure 36. iPSC Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 37. Market Share of iPSC Therapy by Player Revenue in 2025
Figure 38. Top 3 iPSC Therapy Players Market Share in 2025
Figure 39. Top 6 iPSC Therapy Players Market Share in 2025
Figure 40. Global iPSC Therapy Consumption Value Share by Type (2021-2026)
Figure 41. Global iPSC Therapy Market Share Forecast by Type (2027-2032)
Figure 42. Global iPSC Therapy Consumption Value Share by Application (2021-2026)
Figure 43. Global iPSC Therapy Market Share Forecast by Application (2027-2032)
Figure 44. North America iPSC Therapy Consumption Value Market Share by Type (2021-2032)
Figure 45. North America iPSC Therapy Consumption Value Market Share by Application (2021-2032)
Figure 46. North America iPSC Therapy Consumption Value Market Share by Country (2021-2032)
Figure 47. United States iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 48. Canada iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 49. Mexico iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 50. Europe iPSC Therapy Consumption Value Market Share by Type (2021-2032)
Figure 51. Europe iPSC Therapy Consumption Value Market Share by Application (2021-2032)
Figure 52. Europe iPSC Therapy Consumption Value Market Share by Country (2021-2032)
Figure 53. Germany iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 54. France iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 55. United Kingdom iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 56. Russia iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 57. Italy iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 58. Asia-Pacific iPSC Therapy Consumption Value Market Share by Type (2021-2032)
Figure 59. Asia-Pacific iPSC Therapy Consumption Value Market Share by Application (2021-2032)
Figure 60. Asia-Pacific iPSC Therapy Consumption Value Market Share by Region (2021-2032)
Figure 61. China iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 62. Japan iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 63. South Korea iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 64. India iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 65. Southeast Asia iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 66. Australia iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 67. South America iPSC Therapy Consumption Value Market Share by Type (2021-2032)
Figure 68. South America iPSC Therapy Consumption Value Market Share by Application (2021-2032)
Figure 69. South America iPSC Therapy Consumption Value Market Share by Country (2021-2032)
Figure 70. Brazil iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 71. Argentina iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 72. Middle East & Africa iPSC Therapy Consumption Value Market Share by Type (2021-2032)
Figure 73. Middle East & Africa iPSC Therapy Consumption Value Market Share by Application (2021-2032)
Figure 74. Middle East & Africa iPSC Therapy Consumption Value Market Share by Country (2021-2032)
Figure 75. Turkey iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 76. Saudi Arabia iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 77. UAE iPSC Therapy Consumption Value (2021-2032) & (USD Million)
Figure 78. iPSC Therapy Market Drivers
Figure 79. iPSC Therapy Market Restraints
Figure 80. iPSC Therapy Market Trends
Figure 81. Porters Five Forces Analysis
Figure 82. iPSC Therapy Industrial Chain
Figure 83. Methodology
Figure 84. Research Process and Data Source
